TSPYL1 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of the TSPYL1 protein, a member of the Testis-Specific Y-like (TSPY) protein family. TSPYL1 plays a significant role in regulating various cellular processes, including gene expression, cell cycle progression, and chromatin remodeling. It is thought to influence the stability and function of proteins involved in transcriptional regulation, acting as a modulator of cellular signaling pathways. TSPYL1 is known to interact with key proteins in the nucleus, regulating the expression of genes that are crucial for maintaining cellular homeostasis. TSPYL1 inhibitors work by binding to functional domains of the protein, preventing its interaction with other proteins or disrupting its ability to bind to DNA or chromatin structures.
The chemical design of TSPYL1 inhibitors typically focuses on achieving high specificity for TSPYL1 without affecting other members of the TSPY family, which may have similar structural domains. These inhibitors are often small molecules with chemical groups that precisely target regions of TSPYL1 critical for its function, such as protein-protein interaction surfaces or areas responsible for nuclear localization. By inhibiting TSPYL1, these compounds can affect the protein's regulatory role in gene expression and cellular growth. Researchers studying TSPYL1 inhibitors focus on understanding how these compounds alter the protein's ability to modulate gene expression and how these changes influence cellular pathways. This research provides insights into the molecular mechanisms by which TSPYL1 contributes to cellular regulation, enhancing the understanding of protein function in gene regulation and cell cycle control.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
Aurora kinases play pivotal roles in mitosis. If TSPYL1 is indeed involved in cell cycle regulation, inhibiting these kinases might modulate its function. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
As a microtubule depolymerizing agent, Nocodazole arrests cells in mitosis. Given potential roles of TSPYL1 in cell cycle, this can indirectly highlight its function in mitotic progression. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $211.00 | 8 | |
A dual PI3K/mTOR inhibitor can unravel TSPYL1's involvement in pathways mediated by PI3K signaling, given the centrality of this pathway in multiple cellular processes. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
BMP signaling is integral to cell differentiation and growth. If TSPYL1 is linked, inhibiting this pathway might shed light on such associations. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src kinases are implicated in numerous pathways, including cell growth and differentiation. Inhibiting Src might elucidate any TSPYL1-associated signaling. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
Inhibiting FGFR can highlight TSPYL1's role in growth factor-mediated pathways, especially if it's involved in cell proliferation. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
As a CDK inhibitor, this can reveal TSPYL1's function in cell cycle phases regulated by cyclin-dependent kinases. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $202.00 $811.00 | 16 | |
If TSPYL1 is involved in TGF-β signaling, a pathway fundamental to cell growth and differentiation, this ALK inhibitor might indirectly influence its function. | ||||||
GSK 429286 | 864082-47-3 | sc-361200 sc-361200B sc-361200A | 1 mg 5 mg 10 mg | $40.00 $125.00 $235.00 | ||
By inhibiting ROCK1 and 2, TSPYL1's potential involvement in processes like cell motility and contractility can be assessed. | ||||||
BML-277 | 516480-79-8 | sc-200700 sc-200700A | 10 mg 50 mg | $132.00 $492.00 | 2 | |
Targeting Chk2, a key player in DNA damage response, can provide insights into TSPYL1's role in genome integrity maintenance. | ||||||